Sirolimus Eluting Coronary Stent System(Abluminus, Mitigator , Nostrum , Amazonia-SIR , ihtDEStiny®BD, Agile, Minoris, Serpentis, Crocus, Abluminus DES+, Future, Fusion, Abluminus – DM , Abluminus – AMI & Abrax CoCr)
- UID
- MFG/MD/2020/000235_4aafa80b92c805adac1a2544a2041a8b_f77d1d298aebbb10f4c467bfd7b6169c
- Device class
- Class D
- Brand name
- Magic Touch - AVF
- License holder
- Envision Scientific Pvt. Ltd.
- Approving authority
- Central Drug Standards Control Organization, Ahmedabad
- Product information
- The Sirolimus Eluting Coronary Stent System is indicated for improving luminal diameter in patients with diabetes mellitus, acute myocardial infarction, symptomatic heart disease, stable angina, unstable angina or documented silent ischemia due to atherosclerotic lesions in native coronary arteries with reference vessel diameter 2.25mm to 4.00mm and lesions of lesions of length ≤ 40 mm
Sirolimus Eluting Coronary Stent System(Abluminus, Mitigator , Nostrum , Amazonia-SIR , ihtDEStiny®BD, Agile, Minoris, Serpentis, Crocus, Abluminus DES+, Future, Fusion, Abluminus – DM , Abluminus – AMI & Abrax CoCr) is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/MD/2020/000235_4aafa80b92c805adac1a2544a2041a8b_f77d1d298aebbb10f4c467bfd7b6169c. This device is marketed under the brand name Magic Touch - AVF. The license holder is Envision Scientific Pvt. Ltd., and it is classified as Device Class Class D. The approving authority is Central Drug Standards Control Organization, Ahmedabad.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.